ERBB2 and breast cancer: These cell lines are models for the HER2/neu positive class of breast cancer (Figure 2), and the patients carrying these kinds of breast tumors (about 15% of all breast cancers) can be therapeutically treated with inhibitors of the HER2/neu receptor.